Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy
Miranda P. Steenbeek(Radboud University Nijmegen), Rosella Hermens(Radboud University Nijmegen), Joanne A. de Hullu(Radboud University Nijmegen), S.F.P.J. Coppus(Radboud University Nijmegen), Jurgen M.J. Piek(Radboud University Nijmegen), Marc van Beurden(Oncode Institute), Ronald P. Zweemer(Cancer Genomics Centre), Majke H.D. van Bommel(Radboud University Nijmegen), Monique M.A. Brood-van Zanten(The Netherlands Cancer Institute), Helena C. van Doorn, José H.M. Keurentjes(University Medical Center Groningen), Charlotte G. J. Penders(Maastricht University Medical Centre), Marline G. Harmsen(Radboud University Nijmegen), M. Caroline Vos(Elisabeth-TweeSteden Ziekenhuis), Joanna IntHout(Radboud University Nijmegen), Katja N. Gaarenstroom(Radboud University Nijmegen), Mirjam J. A. Apperloo(Medisch Centrum Leeuwarden), Luc R.C.W. van Lonkhuijzen(University of Amsterdam)
Cited by 6
Related Papers
Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs
|Cancer Treatment Reviews|2016|616
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriers
|Journal of Medical Genetics|2015|567
Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health‐related quality of life in breast cancer patients and survivors—a meta‐analysis
|Psycho-Oncology|2010|450
Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod
|New England Journal of Medicine|2008|397
The accuracy of hysterosalpingography in the diagnosis of tubal pathology: a meta-analysis
|Fertility and Sterility|1995|344